GW Pharmaceuticals' GAAP loss for 2020 was $58.128 million, up 6.4 times from $9.019 million in the previous year. Revenue increased 69.3% to $527.205 million, up from $311.332 million a year earlier.
GW Pharmaceuticals' GAAP loss for 2020 was $58.128 million, up 6.4 times from $9.019 million in the previous year. Revenue increased 69.3% to $527.205 million, up from $311.332 million a year earlier. 
ir.gwpharm.com
English (US) 